A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma
LXS196(一种蛋白激酶C (PKC) 抑制剂)治疗转移性葡萄膜黑色素瘤的I期临床试验
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-022-02133-6
Piperno-Neumann, S; Carlino, M S; Boni, V; Loirat, D; Speetjens, F M; Park, J J; Calvo, E; Carvajal, R D; Nyakas, M; Gonzalez-Maffe, J; Zhu, X; Shirley, M D; Ramkumar, T; Fessehatsion, A; Burks, H E; Yerramilli-Rao, P; Kapiteijn, E